Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis
1998

TP53 Accumulation in Bladder Cancer Linked to Poor Prognosis

Sample size: 54 publication Evidence: moderate

Author Information

Author(s): R Abdel-Fattah, C Challen, TRL Griffiths, MC Robinson, DE Neal, J Lunec

Primary Institution: University of Newcastle upon Tyne

Hypothesis

Is there a relationship between TP53 nuclear accumulation and mutations in bladder cancer, and how does this relate to patient survival?

Conclusion

TP53 accumulation often occurs without mutations and is associated with poor survival in bladder cancer patients.

Supporting Evidence

  • TP53 nuclear accumulation was significantly associated with higher histological stage and grade.
  • 33% of cases showed TP53 mutations, with clustering in exons 7 and 8.
  • Patients with TP53 accumulation in more than 50% of tumor nuclei had decreased survival.

Takeaway

This study found that many bladder cancer patients have a lot of a protein called TP53, even when they don't have the usual mutations in the gene that makes it, and this can mean they might not live as long.

Methodology

Microdissection of paraffin-embedded sections and PCR-based direct DNA sequencing were used to analyze TP53 accumulation and mutations in bladder cancer samples.

Limitations

The study may not account for mutations outside of exons 4-9 of the TP53 gene.

Participant Demographics

Patients with transitional cell carcinoma of the bladder.

Statistical Information

P-Value

0.0003

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication